Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-44872

Single-particle
3.36 Å
EMD-44872
3D View Gallery
Deposition: 13/05/2024
Map released: 18/12/2024
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-44872
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9bsu summary report (pdf.gz) Map and 9bsu FULL report (pdf.gz)
EMICSS annotations (xml)

EBOV GP/Nanosota-EB1

EMD-44872

Single-particle
3.36 Å
EMD-44872
3D View Gallery
Deposition: 13/05/2024
Map released: 18/12/2024
Last modified: 29/01/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Ebola virus, Vicugna pacos
Sample: EBOV GP/Nanosota-EB1 complex
Fitted models: 9bsu

Deposition Authors: Bu F, Ye G, Liu B , Li F
Discovery of Nanosota-EB1 and -EB2 as Novel Nanobody Inhibitors Against Ebola Virus Infection.
Bu F, Ye G, Morsheimer K , Mendoza A, Turner-Hubbard H, Herbst M, Spiller B, Wadzinski BE, Eaton B, Anantpadma M, Yang G, Liu B , Davey R, Li F
(2024) PLoS Pathog , 20 , e1012817 - e1012817
PUBMED: 39715280
DOI: doi:10.1371/journal.ppat.1012817
ISSN: 1553-7374